Orthobiologics Devices And Equipment Market Report 2026

Orthobiologics Devices And Equipment Market Overview

• Orthobiologics Devices And Equipment market size has reached to $5.99 billion in 2025 • Expected to grow to $8.64 billion in 2030 at a compound annual growth rate (CAGR) of 8% • Growth Driver: Increasing Prevalence Of Orthopedic Disorders Fueling The Growth Of The Market Due To Rising Demand For Advanced Regenerative Treatment Solutions • Market Trend: Advanced Regenerative Gel Aims To Enhance Bone Healing • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Orthobiologics Devices And Equipment Market?

Orthro biologic devices are implants composed of cells and proteins that are naturally found in the human body and that provide accelerated healing by stimulating efficient regrowth of musculoskeletal tissues, including bones, cartilage, tendons, and ligaments. The main product types of Ortho biologics devices and equipment are demineralized bone matrix, synthetic bone substitutes, stem cell therapy, plasma-rich protein, viscosupplementation, bone morphogenetic protein, and synthetic orthobiologics. Stem cell therapy is promoting the repair response of diseased, dysfunctional, or injured tissue using stem cells or their derivatives. The various applications involved are osteoarthritis and degenerative arthritis, soft-tissue injuries, fracture recovery, maxillofacial and dental applications, spinal fusion, trauma repair, and reconstructive surgery that are used by various end-users such as hospitals, orthopedic clinics, and others.

What Is The Orthobiologics Devices And Equipment Market Growth Forecast?

The orthobiologics devices and equipment market size is expected to see strong growth in the next few years. It will grow to $8.64 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to aging population growth, regenerative medicine innovation, minimally invasive treatment demand, reimbursement expansion, technological advancements in biomaterials. Major trends in the forecast period include rising adoption of regenerative therapies, growth in sports injury treatments, increasing use of stem cell-based products, preference for non-surgical orthopedic treatments, expansion of orthopedic clinics.

Global Orthobiologics Devices And Equipment Market Segmentation

1) By Product Type: Demineralized Bone Matrix, Synthetic Bone Substitutes, Stem Cell Therapy, Plasma-Rich Protein, Viscosupplementation, Bone Morphogenetic Protein, Synthetic Orthobiologics 2) By Application: Osteoarthritis And Degenerative Arthritis, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial And Dental Applications, Spinal Fusion, Trauma Repair, Reconstructive Surgery 3) By End Use: Hospitals, Orthopedic Clinics, Other End Users Subsegments: 1) By Demineralized Bone Matrix: Injectable Demineralized Bone Matrix, Paste And Putty Forms, Demineralized Bone Matrix Scaffolds 2) By Synthetic Bone Substitutes: Calcium Phosphate Ceramics, Bioactive Glasses, Polymers And Composites 3) By Stem Cell Therapy: Adipose-Derived Stem Cell Products, Bone Marrow-Derived Stem Cell Products, Umbilical Cord Blood-Derived Stem Cell Products 4) By Plasma-Rich Protein: Platelet-Rich Plasma (PRP) Products, Platelet-Rich Fibrin (PRF) Products 5) By Viscosupplementation: Hyaluronic Acid Injections, Combination Viscosupplementation Products 6) By Bone Morphogenetic Protein (BMP): Recombinant Bone Morphogenetic Proteins, BMP Delivery Systems 7) By Synthetic Orthobiologics: Growth Factor-Enhanced Products, Biodegradable Scaffolds With Bioactive Agents, Other Synthetic Formulations

What Is The Driver Of The Orthobiologics Devices And Equipment Market?

The increasing prevalence of orthopedic disorders is expected to propel the growth of the orthobiologics devices and equipment market going forward. Orthopedic disorders refer to conditions that affect the musculoskeletal system, including bones, joints, muscles, ligaments, tendons, and nerves. The demand for orthopedic treatments is increasing due to the aging global population as older individuals are more prone to musculoskeletal disorders such as osteoarthritis, osteoporosis, and fractures. Orthobiologics devices and equipment aid in orthopedic disorders by supporting natural tissue regeneration, helping restore bone and joint function more effectively. They improve treatment outcomes by enhancing healing efficiency and reducing recovery time for patients. For instance, in August 2023, according to a survey study by the Institute for Health Metrics and Evaluation, a US-based public health research institute, 15% of individuals aged 30 and older had osteoarthritis in 2023, and the number of affected individuals is projected to reach around 1 billion by 2050. Therefore, the increasing prevalence of orthopedic disorders is driving the growth of the orthobiologics devices and equipment industry.

Key Players In The Global Orthobiologics Devices And Equipment Market

Major companies operating in the orthobiologics devices and equipment market are BONESUPPORT AB, Medtronic plc, Kuros Biosciences Ltd., Stryker Corporation, Baxter International Inc., DePuy Synthes, Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Arthrex Inc., Enovis Corp., Integra Lifesciences Holding Corporation, NuVasive Inc., Globus Medical Inc., Bioventus LLC, Orthofix Medical Inc., SeaSpine Holdings Corporation, Xtant Medical Holdings Inc., Acumed LLC, Bone Biologics Corp.

Global Orthobiologics Devices And Equipment Market Trends and Insights

Major companies operating in the orthobiologics devices and equipment market are focusing on developing advanced regenerative technologies, such as synthetic bone fusion gels, to improve surgical outcomes, enhance healing, and reduce complications. Synthetic bone fusion gels refer to advanced biomaterial formulations that act as a scaffold and delivery system for growth factors, promoting bone growth in spinal fusion and orthopedic procedures. For instance, in January 2024, Renovos Biologics Ltd., a UK-based biomaterial company and investee of Biocomposites, received Food and Drug Administration (FDA) Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, Renovite BMP-2. It is a novel, injectable, and moldable gel designed to confine and retain bone morphogenetic protein-2 (BMP-2) directly at the surgical site. This technology aims to promote effective bone healing while minimizing the risk of ectopic bone formation and other soft-tissue complications associated with older carrier systems, enabling a more controlled and efficient fusion process.

What Are Latest Mergers And Acquisitions In The Orthobiologics Devices And Equipment Market?

In January 2023, Zimmer Biomet Holdings Inc., a US-based medical technology company, acquired Embody Inc. for an undisclosed amount. This acquisition aims to strengthen Zimmer Biomet’s expanding sports medicine portfolio by integrating Embody’s innovative soft tissue healing solutions and supporting the company’s long-term transformation strategy. Embody Inc. is a US-based medical device company offering collagen-based soft-tissue regeneration implants for orthobiologics devices and equipment.

Regional Outlook

North America was the largest region in the global Ortho biologics devices and equipment market in 2025. Western Europe was the second-largest region in the orthobiologics devices and equipment market report. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Orthobiologics Devices And Equipment Market?

The orthobiologics devices and equipment market consists of sales of demineralized bone matrix, synthetic bone substitutes, stem cell therapy, plasma-rich protein, viscosupplementation, bone morphogenetic protein, and other synthetic orthobiologics. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.